7-142942917-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1
The NM_000420.3(KEL):āc.1899A>Gā(p.Leu633Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0123 in 1,614,064 control chromosomes in the GnomAD database, including 1,890 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.062 ( 969 hom., cov: 33)
Exomes š: 0.0071 ( 921 hom. )
Consequence
KEL
NM_000420.3 synonymous
NM_000420.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.380
Genes affected
KEL (HGNC:6308): (Kell metallo-endopeptidase (Kell blood group)) This gene encodes a type II transmembrane glycoprotein that is the highly polymorphic Kell blood group antigen. The Kell glycoprotein links via a single disulfide bond to the XK membrane protein that carries the Kx antigen. The encoded protein contains sequence and structural similarity to members of the neprilysin (M13) family of zinc endopeptidases. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 7-142942917-T-C is Benign according to our data. Variant chr7-142942917-T-C is described in ClinVar as [Benign]. Clinvar id is 3056220.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.38 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.209 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KEL | NM_000420.3 | c.1899A>G | p.Leu633Leu | synonymous_variant | 17/19 | ENST00000355265.7 | NP_000411.1 | |
KEL | XM_005249993.2 | c.1935A>G | p.Leu645Leu | synonymous_variant | 17/19 | XP_005250050.1 | ||
KEL | XM_047420357.1 | c.1788A>G | p.Leu596Leu | synonymous_variant | 16/18 | XP_047276313.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KEL | ENST00000355265.7 | c.1899A>G | p.Leu633Leu | synonymous_variant | 17/19 | 1 | NM_000420.3 | ENSP00000347409.2 | ||
KEL | ENST00000470850.1 | n.199A>G | non_coding_transcript_exon_variant | 3/4 | 2 | |||||
KEL | ENST00000478969.1 | n.238A>G | non_coding_transcript_exon_variant | 1/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0618 AC: 9400AN: 152064Hom.: 969 Cov.: 33
GnomAD3 genomes
AF:
AC:
9400
AN:
152064
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0174 AC: 4362AN: 251392Hom.: 411 AF XY: 0.0122 AC XY: 1662AN XY: 135880
GnomAD3 exomes
AF:
AC:
4362
AN:
251392
Hom.:
AF XY:
AC XY:
1662
AN XY:
135880
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00714 AC: 10442AN: 1461882Hom.: 921 Cov.: 33 AF XY: 0.00621 AC XY: 4513AN XY: 727248
GnomAD4 exome
AF:
AC:
10442
AN:
1461882
Hom.:
Cov.:
33
AF XY:
AC XY:
4513
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0619 AC: 9414AN: 152182Hom.: 969 Cov.: 33 AF XY: 0.0582 AC XY: 4329AN XY: 74396
GnomAD4 genome
AF:
AC:
9414
AN:
152182
Hom.:
Cov.:
33
AF XY:
AC XY:
4329
AN XY:
74396
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
41
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
KEL-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at